Publicacions en col·laboració amb investigadors/es de Hospital Ramón y Cajal (49)

2024

  1. Biomarkers in breast cancer 2024: an updated consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology

    Clinical and Translational Oncology

  2. CDH1 methylation analysis in invasive lobular breast carcinomas with and without gene mutation

    Virchows Archiv, Vol. 485, Núm. 2, pp. 291-297

  3. Epigenetic Fingerprint of the SARS-CoV-2 Infection in the Lung of Lethal COVID-19

    Chest, Vol. 165, Núm. 4, pp. 820-824

  4. Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors

    American Journal of Surgical Pathology

  5. Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of Gynecological Pathologists (ISGyP)

    International Journal of Gynecological Pathology, Vol. 43, Núm. 5, pp. 436-446

  6. Postmenopausal onset of androgen excess: a diagnostic and therapeutic algorithm based on extensive clinical experience

    Journal of Endocrinological Investigation, Vol. 47, Núm. 8, pp. 2007-2020

  7. Single-cell RNA sequencing in endometrial cancer: exploring the epithelial cells and the microenvironment landscape

    Frontiers in Immunology, Vol. 15

2023

  1. Application of Ultrasound Scores (Subjective Assessment, Simple Rules Risk Assessment, ADNEX Model, O-RADS) to Adnexal Masses of Difficult Classification

    Diagnostics, Vol. 13, Núm. 17

  2. Breast metastases from non-primary breast malignancies: What should we know?

    Breast disease, Vol. 42, Núm. 1, pp. 223-228

  3. Contribution of Outpatient Ultrasound Transvaginal Biopsy and Puncture in the Diagnosis and Treatment of Pelvic Lesions: A Bicenter Study

    Diagnostics, Vol. 13, Núm. 3

  4. Correction to: Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity (Current Oncology Reports, (2023), 25, 10, (1081-1094), 10.1007/s11912-023-01434-0)

    Current Oncology Reports

  5. Evaluation of ERBB2 mRNA Expression in HER2-Equivocal (2+) Immunohistochemistry Cases

    Cancers, Vol. 15, Núm. 6

  6. Extramammary Paget Disease: a Therapeutic Challenge, for a Rare Entity

    Current Oncology Reports, Vol. 25, Núm. 10, pp. 1081-1094

  7. Post-mortem findings in Spanish patients with COVID-19; a special focus on superinfections

    Frontiers in Medicine, Vol. 10

  8. T regulatory lymphocytes specific for SARS-CoV-2 display increased functional plasticity

    Clinical Immunology, Vol. 256

  9. The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)

    International journal of molecular sciences, Vol. 24, Núm. 13

  10. Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer

    Clinical and Translational Oncology, Vol. 25, Núm. 4, pp. 1124-1131

2022

  1. Biomarcadores en cáncer invasor de mama

    Revisiones en Cancer, Vol. 36, Núm. 4, pp. 185-196

  2. Cytological and molecular characterization of secretory breast carcinoma

    Diagnostic Cytopathology, Vol. 50, Núm. 7, pp. E174-E180

  3. Differences in the Molecular Profile between Primary Breast Carcinomas and Their Cutaneous Metastases

    Cancers, Vol. 14, Núm. 5